Announcements - Search results

Search results: Company announcements for
PROTEOMICS INTERNATIONAL LABORATORIES LTD (PIQ)
Released between 20/01/2018 and 20/07/2018

Didn't find the announcement you were after? Search again.

Announcements released as PIQ
Date Price sens. Headline
17/07/2018
9:18 AM
asterix Proteomics secures major contract - nears cash flow positive
2 pages 232.5KB
21/06/2018
9:21 AM
asterix Further information on new licence deals in USA and Mexico
2 pages 229.1KB
18/06/2018
8:56 AM
asterix Proteomics signs deal with Patia for PromarkerD in Mexico
3 pages 235.4KB
28/05/2018
9:44 AM
asterix Proteomics signs deal to launch PromarkerD test in US market
3 pages 250.1KB
22/05/2018
9:49 AM
  Appendix 3B - Issue of Employee Options
9 pages 185.0KB
26/04/2018
8:38 AM
asterix Appendix 4C - March 2018 Quarterly Report
7 pages 823.3KB
23/04/2018
4:12 PM
  Change of Directors' Interest Notices
4 pages 330.8KB
19/04/2018
8:41 AM
asterix Europe PromarkerD patent granted for diabetic kidney disease
1 page 221.8KB
16/04/2018
2:25 PM
asterix Underwriters take final $342,000 of Proteomics Options
2 pages 230.6KB
16/04/2018
2:21 PM
  Change in substantial holding
2 pages 11.8MB
16/04/2018
2:17 PM
  Change in substantial holding
2 pages 1.5MB
16/04/2018
2:15 PM
  Change in substantial holding
2 pages 118.7KB
16/04/2018
2:13 PM
  Appendix 3B
9 pages 384.2KB
16/04/2018
2:09 PM
  Secondary trading notice
1 page 212.3KB
06/04/2018
9:32 AM
asterix Conversion of 90% of Proteomics Options raises of $3m
2 pages 230.0KB
06/04/2018
9:28 AM
  Change of Director's Interest Notice
3 pages 225.8KB
06/04/2018
9:25 AM
  Appendix 3B - Exercise of options
9 pages 184.8KB
06/04/2018
9:19 AM
  Secondary trading notice
1 page 214.5KB
29/03/2018
9:33 AM
  Change of Director's Interest Notice
3 pages 182.6KB
29/03/2018
9:30 AM
  Appendix 3B - Exercise of options
9 pages 357.4KB
29/03/2018
9:25 AM
  Secondary Trading Notice
1 page 154.0KB
23/03/2018
11:05 AM
asterix Directors Exercise PIQ Options
2 pages 229.0KB
23/03/2018
10:51 AM
  Change of Directors' Interest Notices
14 pages 843.6KB
23/03/2018
10:46 AM
  Appendix 3B - Exercise of options
9 pages 357.3KB
23/03/2018
10:43 AM
  Secondary Trading Notice
1 page 166.8KB
15/03/2018
4:03 PM
  Appendix 3B - Expiry of Options
10 pages 490.6KB
14/03/2018
9:58 AM
asterix Proteomics secures underwriting - PIQ Options to raise $3.4m
2 pages 228.5KB
08/03/2018
12:37 PM
  Secondary trading notice
1 page 214.5KB
08/03/2018
12:30 PM
  Appendix 3B
9 pages 362.1KB
07/03/2018
9:41 AM
asterix Proteomics launches PromarkerD
2 pages 235.2KB
05/03/2018
3:13 PM
  Proteomics completes investment in CPR Pharma Services
1 page 220.1KB
05/03/2018
3:11 PM
  Appendix 3B
9 pages 186.7KB
05/03/2018
3:09 PM
  Secondary trading notice
1 page 162.6KB
19/02/2018
12:10 PM
  Expiry of Options - Letter to Option Holders
5 pages 1.2MB
16/02/2018
3:28 PM
asterix Appendix 4D and Interim Financial Report
22 pages 1.2MB
15/02/2018
6:12 PM
  Appendix 3B
9 pages 371.2KB
07/02/2018
11:53 AM
  Proteomics International Investor Presentation
22 pages 3.9MB
06/02/2018
9:19 AM
  Proteomics International Investor conference call
1 page 212.9KB
05/02/2018
1:51 PM
  Proteomics International Options PIQO Exercised
2 pages 217.2KB
05/02/2018
1:48 PM
  Appendix 3B
9 pages 180.1KB
02/02/2018
9:28 AM
asterix Strategic alliance and investment in CPR Pharma Services
3 pages 237.7KB
29/01/2018
9:19 AM
asterix PromarkerD diabetic kidney disease patent granted in Japan
2 pages 244.0KB
25/01/2018
12:17 PM
asterix Appendix 4C - December 2017 Quarterly Report
8 pages 340.3KB

Useful Information

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.